# OnCo record moma-989 (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/moma-989/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "moma-989" ;
  schema:name "MOMA-989"@en ;
  schema:description "MOMA-989 is an experimental small molecule from MOMA Therapeutics, in preclinical development for homologous recombination deficient tumours."@en ;
  schema:url <https://onco.cc/drugs/moma-989/> ;
  schema:dateModified "2026-11-03"^^xsd:date ;
  schema:citation <https://momatx.com/posts/moma-therapeutics-provides-corporate-update-and-announces-exclusive-license-agreement-for-selective-parp1-inhibitor/>, <https://momatx.com/posts/moma-therapeutics-provides-corporate-update-and-announces-exclusive-license-agreement-for-selective-parp1-inhibitor/> ;
  onco:status "preclinical" ;
  onco:tag "pipeline" ;
  onco:modality "Small molecule (oral)" ;
  onco:cancers <https://onco.cc/cancers/metastatic-cancer/> ;
  onco:targets <https://onco.cc/targets/parp/> ;
  onco:companies <https://onco.cc/companies/moma-therapeutics/> .
